Table I.
Association between CCEPR expression and clinicopathological characteristics of patients with colorectal cancer.
Variables | Cases (n=58) | Low CCEPR levels (n=33) | High CCEPR levels (n=25) | P-value |
---|---|---|---|---|
Age (years) | 0.384 | |||
≤55 | 31 | 16 | 15 | |
>55 | 27 | 17 | 10 | |
Sex | 0.832 | |||
Male | 38 | 22 | 16 | |
Female | 20 | 11 | 9 | |
Differentiation | 0.032a | |||
Well and moderately | 41 | 27 | 14 | |
Poor | 17 | 6 | 11 | |
Node metastasis | 0.043a | |||
Present | 26 | 11 | 15 | |
Absent | 32 | 22 | 10 | |
Distant metastasis | 0.003a | |||
Present | 9 | 1 | 8 | |
Absent | 49 | 32 | 17 | |
Clinical stage | 0.043a | |||
I–II | 32 | 22 | 10 | |
III–IV | 26 | 11 | 15 |
P<0.05. CCEPR, cervical carcinoma expressed PCNA regulatory lncRNA; lncRNA, long non-coding RNA.